Skip to content
healthcare.dev

Xenazine

NDC 67386-421, tetrabenazine, tablet, from Lundbeck Pharmaceuticals LLC.

Product NDC
67386-421
Status
Listed
Labeler
Lundbeck Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021894
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67386-421 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TETRABENAZINE12.5 mg/1

Pharmacologic classes

Vesicular Monoamine Transporter 2 Inhibitor [EPC]; Vesicular Monoamine Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
67386-421-0167386042101112 TABLET in 1 BOTTLE (67386-421-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac768bab-8afa-4446-bc7f-caeeffec0cda

Use it

Look up 67386-421 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67386-421 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67386-421. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.